- Big Discovery: Clinic practices affect genetic diagnosis rates more than patient traits
- Who it helps: Families seeking answers for rare childhood conditions
- The Catch: Results depend on where you’re tested—standardization is still lacking
This study reveals that your odds of getting a genetic diagnosis may depend less on your DNA—and more on where you get tested.
You’ve waited months. Your child has delays, seizures, or a rare-looking face. Doctors suggest genetic testing. You hope for answers. But what if the clinic you choose changes your chances of finding them?
That’s exactly what this study uncovered.
More kids need answers
Thousands of children in the U.S. are born each year with unexplained health issues. Many have rare genetic conditions. Symptoms can include trouble learning, seizures, heart defects, or unusual physical traits. Without a diagnosis, families face stress, endless tests, and delayed care.
Genetic sequencing—reading a child’s DNA—can help. It’s become a key tool for finding the root cause. But not every test leads to answers. And until now, it wasn’t clear why some clinics find diagnoses more often than others.
Clinics don’t all follow the same playbook
We used to think that a patient’s symptoms, age, or genetic background were the biggest factors in whether a test worked. And yes—kids with multiple health issues are more likely to get a diagnosis. Babies tested before birth (prenatally) have lower odds.
But here’s the twist: the clinic itself plays a bigger role than expected.
Even after accounting for patient traits—like age, sex, or number of symptoms—diagnostic success still varied between clinics. That means two kids with the same condition could get different results just based on where they were tested.
This isn’t about equipment. It’s about how doctors and labs interpret the DNA data.
Like reading a book with missing words
Think of DNA as an instruction manual for the body. A typo in the text can cause disease. Sequencing finds those typos. But not every typo matters.
Geneticists must decide: Is this spelling mistake harmful? Or just a harmless variation?
It’s like finding a typo in a cookbook. Is it in the cake recipe—or the copyright page? That’s where human judgment comes in.
The surprising shift
The study looked at 3,008 kids and pregnant patients across five U.S. clinics from 2017 to 2023. All had exome or genome sequencing. These tests scan large parts of DNA to find errors.
Researchers checked whether factors like race, genetic ancestry, or type of test affected diagnosis rates. They used strict medical guidelines to confirm results.
Overall, 19 out of every 100 patients got a clear genetic diagnosis. That’s about 1 in 5—lower than some past reports.
Kids with more than one major symptom were more likely to be diagnosed. Boys were slightly less likely than girls. And prenatal cases—tests done before birth—had lower success rates.
But race, ethnicity, and genetic ancestry? They didn’t affect results. That’s good news—it means access to diagnosis wasn’t tied to background.
This doesn’t mean this treatment is available yet.
But there’s a catch. Even after adjusting for all patient traits, clinics still differed in their success rates. At first, 10% of the variation came from where the test was done. After adjusting for patient traits, 5.7% of the difference remained.
That’s not small. It means clinic habits—how they review DNA, classify variants, or define a “diagnosis”—still shape outcomes.
What scientists didn’t expect
Sequencing method (exome vs. genome) didn’t change results. Neither did isolated cancer cases. That suggests the analysis, not the test type, is the key variable.
Experts say this highlights the need for more consistent rules. Right now, one lab might call a DNA change “harmful,” while another calls it “uncertain.”
That confusion delays answers.
Where the real problem lies
Imagine two mechanics diagnosing the same car. One says the engine is broken. The other says it’s fine. That’s the challenge in genetic testing today.
Differences in training, software, or internal checklists can lead to different calls—even with the same data.
This study shows those differences are real and measurable.
If you or your child are getting genetic testing, ask:
- What kind of sequencing will be used?
- How do they interpret uncertain results?
- Do they follow national guidelines?
Not all clinics do. And this study shows it can affect your results.
But don’t panic. A negative result doesn’t mean there’s no answer—just that it wasn’t found this time.
Talk to your doctor about whether reanalysis later—or testing at a different center—might help.
It’s not perfect
The study only looked at five sites. All were part of a research network, so results may not reflect every hospital. Also, most data came from academic centers, which may have more expertise than community labs.
And while race and ancestry didn’t affect outcomes here, access to testing still does. Many families face delays due to cost, location, or lack of referrals.
Researchers now urge labs to standardize how they review DNA results. National efforts are underway to create shared tools and checklists.
Future studies will track whether these changes reduce clinic-to-clinic differences. For now, awareness is the first step.
Better consistency could mean faster answers—for more families.
